EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Cripto‐1 acts as a molecular bridge linking nodal to ALK4 via distinct structural domains

Kit-Yee Chu, Amberly N Crawford, Bradon S Krah, Vijayalakshmi Thamilselvan, Anjali Malik, Nina A Aitas, Erik Martinez-Hackert iD

Protein Science · 2025-02 · 34 (2)

DOI: 10.1002/pro.70034 ↗

At a glance

Journal article in Protein Science, published online on 2025-01-22. Written by Kit-Yee Chu and 6 co-authors. Institution: Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan, USA. Major MEDLINE topics: Nodal Protein, GPI-Linked Proteins, Activin Receptors, Type I, Neoplasm Proteins. Cited 4 times so far (Crossref); 43 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIGMS NIH HHS, National Institute of General Medical Sciences.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The TGF‐ β family ligand Nodal is an essential regulator of embryonic development, orchestrating key processes such as germ layer specification and body axis formation through activation of SMAD2/3‐mediated signaling. Significantly, this activation requires the co‐receptor Cripto‐1. However, despite their essential roles in embryogenesis, the molecular mechanism through which Cripto‐1 enables Nodal to activate the SMAD2/3 pathway has remained elusive. Intriguingly, Cripto‐1 also has been shown to antagonize other TGF‐ β family ligands, raising questions about its diverse functions. To clarify how Cripto‐1 modulates TGF‐ β signaling, we integrated AlphaFold3 modeling, surface plasmon resonance (SPR)‐based protein–protein interaction analysis, domain‐specific anti‐Cripto‐1 antibodies, and functional studies in NTERA‐2 cells. In contrast to canonical TGF‐ β signaling, where ligands bridge type I and type II receptors for activation, Nodal, bound to the type II receptor, utilizes Cripto‐1 to recruit the type I receptor ALK4, forming a unique ternary complex for SMAD2/3 activation. Our molecular characterization of Cripto‐1‐mediated Nodal signaling clarifies the unique role of this enigmatic co‐receptor and advances our understanding of signaling regulation within the TGF‐ β family. These insights have potential implications for both developmental biology and cancer research.

Subjects

MeSH terms (MEDLINE)

Nodal ProteinGPI-Linked ProteinsActivin Receptors, Type INeoplasm ProteinsIntercellular Signaling Peptides and ProteinsEpidermal Growth FactorHumansSignal TransductionSmad2 ProteinSmad3 ProteinProtein Domains

Author keywords

ALK4AlphaFoldCripto‐1EGF‐CFC proteinsco‐receptormolecular modelingnodalprotein–protein interactionsignaling transductiontransforming growth factor beta (TGF‐β)

Substances

Nodal ProteinTDGF1 protein, humanGPI-Linked ProteinsNODAL protein, humanActivin Receptors, Type IACVR1B protein, humanNeoplasm ProteinsIntercellular Signaling Peptides and ProteinsSmad2 ProteinSMAD2 protein, human

Authors and institutions

  • Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan, USA.
  • Department of Structural Biology, Van Andel Institute, Grand Rapids, Michigan, USA.

ORCID profiles: Erik Martinez-Hackert

Funding

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences

Cite

APA

Chu, K. Y., Crawford, A. N., Krah, B. S., Thamilselvan, V., Malik, A., Aitas, N. A., & Martinez-Hackert, E. (2025). Cripto‐1 acts as a molecular bridge linking nodal to ALK4 via distinct structural domains. Protein Science, 34(2). https://doi.org/10.1002/pro.70034

Vancouver

Chu KY, Crawford AN, Krah BS, Thamilselvan V, Malik A, Aitas NA, et al. Cripto‐1 acts as a molecular bridge linking nodal to ALK4 via distinct structural domains. Protein Science. 2025;34(2). doi:10.1002/pro.70034

BibTeX
@article{Chu2025,
  author = {Chu, Kit-Yee and Crawford, Amberly N and Krah, Bradon S and Thamilselvan, Vijayalakshmi and Malik, Anjali and Aitas, Nina A and Martinez-Hackert, Erik},
  title = {Cripto‐1 acts as a molecular bridge linking nodal to ALK4 via distinct structural domains},
  journal = {Protein Science},
  year = {2025},
  volume = {34},
  number = {2},
  doi = {10.1002/pro.70034}
}
Start for free →